| Issue Date | Title | Author(s) |
| 4-Feb-2026 | 3-(Pyridine-3-ylmethylene)chroman-4-one and tetralone derivatives: synthesis, <i>Mycobacterium tuberculosis</i> CYP121A1 enzyme inhibition and antimycobacterial activity <i>vs</i> drug-sensitive and drug-resistant strains | Alshabani, LA; Abdali, JM; Brown, AK; de Sousa, DP; Willcocks, S; Kumar, A; Alhejaili, AYG; Estrada, DF; Simons, C |
| 6-May-2025 | Development of Carprofen analogues with activity against Mycobacterium tuberculosis | Martin, LT; Daniel, C; Guldberg-Allen, M; Navaratnarajah, A; Anselmi, S; Burova, TMD; Willcocks, S; Hailes, HC; Bhakta, S |
| 18-Jul-2025 | Dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in poultry in Zimbabwe | Katsande, P; Davies, AR; Chisnall, T; Vhoko-Tapesana, K; Willcocks, S; Majuru, CS; Mubau, T; Stabler, RA; Card, RM |
| 12-Feb-2026 | Identification of multiple Acinetobacter baumannii protein antigens as targets for potential immunotherapies using a novel protein microarray screening approach | Palethorpe, S; Ercoli, G; Ramos-Sevillano, E; Kamuyu, G; Campo, J; Willcocks, S; Nakajima, R; Felgner, P; Wren, B; Lertmemongkolchai, G; Stabler, R; Brown, J |
| 20-Nov-2024 | Respiratory bioenergetics is enhanced in human, but not bovine macrophages after exposure to M. bovis PPD: Exploratory insights into overall similar Cellular Metabolic Profiles | Bartens, MC; Willcocks, S; Werling, D; Gibson, AJ |
